These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17111685)

  • 1. [The effectiveness of carvedilol in heart failure].
    Kárpáti K; Brodszky V; Farsang C; Jermendy G; Vándorfi G; Zámolyi K; Gulácsi L
    Orv Hetil; 2006 Oct; 147(40):1931-7. PubMed ID: 17111685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.
    Fowler MB; Vera-Llonch M; Oster G; Bristow MR; Cohn JN; Colucci WS; Gilbert EM; Lukas MA; Lacey MJ; Richner R; Young ST; Packer M
    J Am Coll Cardiol; 2001 May; 37(6):1692-9. PubMed ID: 11345386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.
    Packer M; Colucci WS; Sackner-Bernstein JD; Liang CS; Goldscher DA; Freeman I; Kukin ML; Kinhal V; Udelson JE; Klapholz M; Gottlieb SS; Pearle D; Cody RJ; Gregory JJ; Kantrowitz NE; LeJemtel TH; Young ST; Lukas MA; Shusterman NH
    Circulation; 1996 Dec; 94(11):2793-9. PubMed ID: 8941104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program.
    Vera-Llonch M; Menzin J; Richner RE; Oster G
    Ann Pharmacother; 2001; 35(7-8):846-51. PubMed ID: 11485131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of carvedilol for heart failure.
    Delea TE; Vera-Llonch M; Richner RE; Fowler MB; Oster G
    Am J Cardiol; 1999 Mar; 83(6):890-6. PubMed ID: 10190405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
    Stewart S; McMurray JJ; Hebborn A; Coats AJ; Packer M;
    Int J Cardiol; 2005 Apr; 100(1):143-9. PubMed ID: 15820297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol: a review of its use in chronic heart failure.
    Keating GM; Jarvis B
    Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.
    Colucci WS; Packer M; Bristow MR; Gilbert EM; Cohn JN; Fowler MB; Krueger SK; Hershberger R; Uretsky BF; Bowers JA; Sackner-Bernstein JD; Young ST; Holcslaw TL; Lukas MA
    Circulation; 1996 Dec; 94(11):2800-6. PubMed ID: 8941105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of carvedilol on survival in severe chronic heart failure.
    Packer M; Coats AJ; Fowler MB; Katus HA; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Roecker EB; Schultz MK; DeMets DL;
    N Engl J Med; 2001 May; 344(22):1651-8. PubMed ID: 11386263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.
    Packer M; Fowler MB; Roecker EB; Coats AJ; Katus HA; Krum H; Mohacsi P; Rouleau JL; Tendera M; Staiger C; Holcslaw TL; Amann-Zalan I; DeMets DL;
    Circulation; 2002 Oct; 106(17):2194-9. PubMed ID: 12390947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?
    Wollert KC; Drexler H
    Circulation; 2002 Oct; 106(17):2164-6. PubMed ID: 12390940
    [No Abstract]   [Full Text] [Related]  

  • 17. Reimbursement claims analysis of outcomes with carvedilol and metoprolol.
    Luzier AB; Antell LA; Chang LL; Xuan J; Roth DA
    Ann Pharmacother; 2002 Mar; 36(3):386-91. PubMed ID: 11895048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.
    Krum H; Roecker EB; Mohacsi P; Rouleau JL; Tendera M; Coats AJ; Katus HA; Fowler MB; Packer M;
    JAMA; 2003 Feb; 289(6):712-8. PubMed ID: 12585949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
    Cleland JG; Charlesworth A; Lubsen J; Swedberg K; Remme WJ; Erhardt L; Di Lenarda A; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson PA;
    J Am Coll Cardiol; 2006 Apr; 47(8):1603-11. PubMed ID: 16630997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.